ScreenerHero

OILS Nextleaf Solutions Ltd.

CNQ · CA · Healthcare · Drug Manufacturers - Specialty & Generic · nextleafsolutions.com
0.0300CAD+20.00%Mkt Cap: 3.71M $P/E: —

Nextleaf Solutions Ltd., a cannabis extraction technology company, engages in the manufacture and distribution of cannabinoid vapes, oils, and softgels in Canada. The company is involved in toll processing, bulk ingredie…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$66.23BUSDP/E 25.7
TAK
Takeda Pharmaceutical Company Limited
$58.68BUSD
TEVA
Teva Pharmaceutical Industries Limited
$45.70BUSDP/E 65.3
GALD
Galderma Group AG
$43.27BUSDP/E 56.1
HLN
Haleon plc
$39.67BUSDP/E 18.4
SDZ
Sandoz Group AG
$34.93BUSDP/E 60.5
HLN
Haleon plc
$32.73BUSDP/E 19.0
ZOE
Zoetis Inc.
$28.56BUSDP/E 12.2
ZTS
Zoetis Inc.
$29.57BUSDP/E 11.8
UTHR
United Therapeutics Corporation
$23.38BUSDP/E 19.5
VTRS
Viatris Inc.
$20.09BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.43BUSDP/E 112.9
NBIX
Neurocrine Biosciences, Inc.
$14.58BUSDP/E 21.0
IPN
Ipsen S.A.
$12.99BUSDP/E 23.5
ELAN
Elanco Animal Health Incorporated
$11.17BUSD
RDY
Dr. Reddy's Laboratories Limited
$10.22BUSDP/E 27.9
KRK
Krka, d. d.
$8.66BUSDP/E 19.3
ALKS
Alkermes plc
$6.95BUSDP/E 109.1
HIMS
Hims & Hers Health, Inc.
$6.89BUSD
AMRX
Amneal Pharmaceuticals, Inc.
$6.84BUSDP/E 40.1

Key Statistics

Company
Market Cap3.71M USD
Enterprise Value3.94M USD
Revenue (TTM)7.21M USD
Gross Profit2.76M USD
Net Income (TTM)-118.67K USD
Revenue/Share0.06 CAD
Last Price0.0300 CAD
Fiscal Year EndSep 2025
MR QuarterJun 2026
Employees—
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINCA65347A1021
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-19.34
EV/Revenue0.55
P/S0.51
P/B1.36
EPS (TTM)-0.02
EPS (Forward)—
52W Range
0.02508% of range0.0850
52W High0.0850 CAD
52W Low0.0250 CAD
Profitability
Gross Margin33.68%
Oper. Margin-6.93%
EBITDA Margin-2.82%
Profit Margin-1.45%
ROE-3.56%
ROA-2.08%
Growth
Revenue Growth-13.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF302.14K USD
CapEx (TTM)195.02K USD
FCF Margin10.73%
FCF Yield20.84%
Net Debt220.41K USD
Net Debt/EBITDA-1.08
Balance Sheet
Debt/Equity0.10
Current Ratio1.40
Quick Ratio0.36
Book Value/Sh0.02 CAD
Cash/Share0.0010 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 CAD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:3.5
Split DateMar 11, 2019
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.169.94M
Float167.78M
Insiders1.43%
Institutions0.00%
Short Interest
Short Ratio0.0d
Short % Out.0.00%
Shares Short1.76K
Short (prev mo.)46.15K
Technical
SMA 500.0377 (-20.4%)
SMA 2000.0485 (-38.1%)
Beta1.14
S&P 52W Chg16.45%
Avg Vol (30d)75.07K
Avg Vol (10d)47.28K
Technical Indicators
RSI (14)37.1
MACD-0.0052
MACD Signal-0.0043
MACD Hist.-0.0008
BB Upper0.0521 CAD
BB Middle0.0367 CAD
BB Lower0.0214 CAD
BB Width83.33%
ATR (14)0.0037 CAD
Vol Ratio (20d)0.70x